SynCardia Management Team
President & CEO
Michael Garippa is the former CEO and President of TandemHeart. He was recruited by TandemHeart in 2002 as a turnaround expert and stayed on as CEO and President. He took TandemHeart from an R&D firm that had lost an aggregate of $50 million and had no commercial sales to a successful company with over $6 million in net income in the 24 months prior to joining SynCardia.
Prior to joining TandemHeart, Mr. Garippa served as CEO and President of Gateway Home Care. In addition, Mr. Garippa was Founder and CEO of Millennium HomeCare and The Prompt Care Companies. His background also includes being National Sales Manager at Omni Medical and Senior Analyst with the NYC Health and Hospitals Corporation. Mr. Garippa holds a BA degree from Rutgers University and a master's degree from New York University.
Mary Pat Sloan
SVP, Global Certification and Logistics
Mary Pat Sloan was with AlphaGraphics Printshops of the Future for 25 years. She started the domestic and international franchise programs, including setting up and conducting training classes, as well as developing the curriculum and authoring the operating manuals. She was Managing Director of the AlphaGraphics Master Licensee for the former Soviet Union and lived in Russia for five years and Cyprus for two years.
She has an MBA in international management from Thunderbird, 1977. She also has a BS degree in political science from the University of Arizona, 1976. Ms. Sloan was most recently with Invacare Corporation, a home medical device company in Elyria, Ohio, that makes custom wheelchairs and portable oxygen. She has been with SynCardia since December 2005.
Paul Zaman leads the finance and accounting team at SynCardia and brings more than 11 years of experience in financial services. Over the last five years, he has held significant financial planning & analysis (FP&A) roles in both SynCardia and Springleaf Financial Services (currently OneMain Financial). Mr. Zaman has led his FP&A teams on several private equity raises totaling over $20 million as well as helping to secure multiple debt instruments of over $30 million in his career. Recently, Mr. Zaman has led his team through an asset purchase and acquisition of the company by Versa Capital Management, LLC. Mr. Zaman received a BS degree in finance from Metropolitan State University of Denver in 2005 and an MBA from the Eller College of Management at the University of Arizona in 2011.
VP, Manufacturing and Facilities
Brian Brogie has more than 30 years of manufacturing, process improvement and supplier management experience in highly regulated industries, including medical devices. He oversees manufacturing of SynCardia’s product line, which includes the commercially approved 70cc SynCardia temporary Total Artificial Heart; the investigational 50cc Total Artificial Heart for smaller patients; the Companion 2 hospital driver for powering the Total Artificial Heart from implant until the patient stabilizes; and the Freedom® portable driver, a wearable power supply that allows clinically stable patients to be discharged from the hospital.
Prior to joining SynCardia, Brogie served as Director of Manufacturing for Gilead Sciences, Inc., where he led a team responsible for manufacturing two injectable drug products and packaging 12 solid oral dose products. Among his most critical duties were ensuring Current Good Manufacturing Practice (cGMP) compliance, executing spending within a $24 million manufacturing budget and facilitating the introduction of new products to the company’s production line. Brogie previously held similar positions with Oso BioPharmaceuticals and BF Goodrich Aerospace.